These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29773301)

  • 41. Introducing a new scoring system for pap smear in the detection of high-grade squamous intraepithelial lesions in pregnancy (The Luebeck Score).
    Neumann K; Barop C; Cirkel C; Rody A; Beyer DA
    Arch Gynecol Obstet; 2016 Oct; 294(4):855-60. PubMed ID: 27180187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of Abnormal Cervical Cytology in HIVNegative Women Participating in a Cervical Cancer Screening Program in Calmette Hospital, Cambodia.
    Hav M; Eav S; Heang N; Pich P; Lim D; Leang V; Korn A; Lay S; Pluot M; Kruy L
    Asian Pac J Cancer Prev; 2016; 17(7):3101-3. PubMed ID: 27509936
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of a worksite cervical screening initiative to increase Pap smear uptake in Malaysia: a cluster randomized controlled trial.
    Abdullah F; O'Rorke M; Murray L; Su TT
    Biomed Res Int; 2013; 2013():572126. PubMed ID: 24073411
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
    Li Z; Austin RM; Guo M; Zhao C
    Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metastatic breast cancer diagnosed on cervical cytology.
    Yuan L; Oshilaja O; Sierk A; Zhang G; Booth CN; Brainard J; Dyhdalo KS
    Cytopathology; 2021 Jan; 32(1):127-131. PubMed ID: 32789952
    [No Abstract]   [Full Text] [Related]  

  • 46. [The ecologization of the Papanicolaou stain in the diagnosis of cervical cancer].
    Rojas-Zumaran V; Moya-Salazar J
    Rev Med Inst Mex Seguro Soc; 2018 Oct; 56(3):217-225. PubMed ID: 30365481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Eco-Pap: The Ecological Modification of the Papanicolaou Stain for Sustainable Cervical Cancer Diagnosis.
    Moya-Salazar J; Rojas-Zumaran V
    Acta Cytol; 2019; 63(1):35-43. PubMed ID: 30352442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cancer diagnosis after a report of negative cervical cytology.
    Mitchell HS; Giles GG
    Med J Aust; 1996 Mar; 164(5):270-3. PubMed ID: 8628160
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HDFCN: A Robust Hybrid Deep Network Based on Feature Concatenation for Cervical Cancer Diagnosis on WSI Pap Smear Slides.
    Chauhan NK; Singh K; Kumar A; Kolambakar SB
    Biomed Res Int; 2023; 2023():4214817. PubMed ID: 37101692
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving cervical cancer classification in PAP smear images with enhanced segmentation and deep progressive learning-based techniques.
    Mahajan P; Kaur P
    Diagn Cytopathol; 2024 Jun; 52(6):313-324. PubMed ID: 38516853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of papanicolaou (Pap) test rates across Ontario and factors associated with cervical screening.
    Fehringer G; Howlett R; Cotterchio M; Klar N; Majpruz-Moat V; Mai V
    Can J Public Health; 2005; 96(2):140-4. PubMed ID: 15850036
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Pap smear: take two.
    Shulman JJ; Hontz A; Sedlis A; Walters AT; Balin H; LoScuito L
    Am J Obstet Gynecol; 1975 Apr; 121(8):1024-8. PubMed ID: 1119496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The evaluation and interpretation of cervical cytology: application of the likelihood ratio concept.
    Giard RW; Hermans J
    Cytopathology; 1993; 4(3):131-7. PubMed ID: 8343590
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reimbursement Incentives to Improve Adherence to Follow-Up of Cervical Cancer Cytology Screening Results in Peru.
    Ferris DG; Chen J; Isaac A; Braithwaite E; Beideck E; Mikail N; Krotish D; Waller JL
    J Low Genit Tract Dis; 2019 Apr; 23(2):116-123. PubMed ID: 30741754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Delay times to definitive diagnosis after an abnormal Pap smear.
    Mitchell H; Medley G
    Aust N Z J Obstet Gynaecol; 1987 Nov; 27(4):283-6. PubMed ID: 3453664
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cervical cancer screening in Turkey: a community-based experience after 60 years of pap smear usage.
    Demirhindi H; Nazlican E; Akbaba M
    Asian Pac J Cancer Prev; 2012; 13(12):6497-500. PubMed ID: 23464481
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hematoidin crystals in Pap smear: A revisit.
    Thakur A; Sarin H
    Diagn Cytopathol; 2020 Jan; 48(1):92. PubMed ID: 31714034
    [No Abstract]   [Full Text] [Related]  

  • 58. Criminal Justice Involvement and Abnormal Cervical Cancer Screening Results Among Women in an Urban Safety Net Hospital.
    Jodry D; Blemur D; Nguyen ML; Kuhn T; Easley K; Wang H; Ramaswamy M; Birdsong G; Kohut A; Manobianco B; Flowers L
    J Low Genit Tract Dis; 2021 Apr; 25(2):81-85. PubMed ID: 33631779
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DeepCyto: a hybrid framework for cervical cancer classification by using deep feature fusion of cytology images.
    Shinde S; Kalbhor M; Wajire P
    Math Biosci Eng; 2022 Apr; 19(7):6415-6434. PubMed ID: 35730264
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pitfalls in Gynecological Cytology: Review of the Common and Less Frequent Entities in Pap Test.
    Vrdoljak-Mozetič D; Štemberger-Papić S; Verša Ostojić D; Rubeša R; Klarić M; Eminović S
    Acta Cytol; 2024; 68(3):281-298. PubMed ID: 38834045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.